Distrimex. Pharmaceutical Import Profile — France (DGFT 2022–2026)

Name: Distrimex. Pharmaceutical Import Records from India — 4 Products, $3.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Distrimex. — Pharmaceutical Importer Profile (2026) | 4 Products, $3.8M Trade | TransData Nexus

Distrimex.

Pharmaceutical Importer · France · Nutritional Supplements Focus · $3.8M Total Trade · DGFT Verified

Distrimex. is a pharmaceutical importer based in France with a total trade value of $3.8M across 4 products in 2 therapeutic categories. Based on 111 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Distrimex. sources from 21 verified Indian suppliers, with Strides Pharma Science Limited accounting for 44.8% of imports.

Distrimex. — Import Portfolio & Supplier Network

Distrimex. import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Distrimex.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Strides Pharma Science Limited	$6.0M	332	44.8%
Subira Pharmaceuticals Private Limited	$2.4M	203	17.6%
Glenmark Pharmaceuticals Limited	$1.4M	60

What Formulations Does Distrimex. Import?

Formulation	Value	Ships
Vitafer forte syrup of iron and folic	$673.5K	19
Paluva cpr 80/480MG (bt6)(antimalarial	$666.7K	21
Clavicin foi-1g/200MG amoxicillin &	$200.0K	4
Solcer - omeprazole for injection 40MG [Pack of x	$192.5K	5
Paluva 80MG INJ 1x6s -details as per invoice no 409/sub/dis/2024 dt	$169.4K	8
Celltriaxon 1g-ceftriaxone injection	$168.8K	4
Solcer-omeprazole for injection 40MG	$128.2K	4
Combiart 80/480MG tablet artemether /	$111.1K	3
Renerve-p capsule [Pack of 3x10s']	$107.5K	5
Vitafer forte syrup of iron and folic acid with vitamin b12 200MG/1.5MG/50mcg 1s 30720.00 x 1s	$100.2K	3
Renerve plus renerve plus capsules	$100.0K	2
Mumfer syrup ci 150 ML (24000 bot)	$100.0K	2
Candid b cream 15 GM (32600 tub)	$100.0K	2
Candid v6 tablets 1x6's + 1 applicator	$100.0K	2
Clavicin foi-1g/200MG amoxicillin & potassium clavulanate for injection(1g/200MG)(Pack of x 1's)	$100.0K	2

Distrimex. imports 654 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Folic	Nutritional Supplements	$2.5M	82	2.4%	4
2	Vitamin	Nutritional Supplements	$1.1M	23	0.8%	12
3	Secnidazole	Advanced Antibiotics	$115.2K	3	0.4%	15
4	Ceftazidime	Advanced Antibiotics	$95.0K	3	0.9%	15

Distrimex. imports 4 pharmaceutical products across 2 categories into France totaling $3.8M.

Distrimex. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Distrimex is a French company specializing in the import and export of fresh fruits and vegetables. Established in 1975 by Mr. Hubert Casal, the company has become a key player in its sector, distributing approximately 50,000 tonnes of produce annually across the globe. Their product range includes apples, pears, apricots, plums, peaches, nectarines, and various other fruits and vegetables. (distrimex.fr)

In 2010, Distrimex expanded its operations by establishing a subsidiary, DISTRIMEX, under the CERP Bretagne Atlantique group. This subsidiary focuses on the distribution, promotion, and regulatory affairs of pharmaceutical and parapharmaceutical products in French and English-speaking African countries, as well as in the French overseas departments, regions, and municipalities (DROM-COM). DISTRIMEX offers logistics expertise and supports laboratories in their business development strategies and interactions with local health authorities.

2Distribution Network

DISTRIMEX operates a bonded warehouse certified by the French National Agency for the Safety of Medicines and Health Products (ANSM). This facility ensures compliance with Good Wholesaler Distribution Practices (GDP) and maintains product storage in a temperature-controlled environment ranging from +15°C to +25°C. The company manages over 1,000 pallets per month, serving 55 clients across 22 territories.

Their logistics capabilities include daily departures of full and mixed trucks within Europe and weekly container shipments to various international markets, including the Middle East, Asia, and India. This extensive network allows DISTRIMEX to meet the requirements of both European and global markets effectively. (distrimex.fr)

3Industry Role

DISTRIMEX serves as a distributor and promoter of pharmaceutical and parapharmaceutical products, primarily focusing on markets in French and English-speaking Africa, as well as the DROM-COM regions. Their role involves managing logistics, regulatory affairs, and promotional activities for laboratories seeking to enter these markets. By leveraging their in-depth knowledge of local markets and regulatory landscapes, DISTRIMEX facilitates the introduction and distribution of pharmaceutical products in these regions.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Distrimex.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

DISTRIMEX's sourcing strategy for pharmaceutical products involves a diverse range of suppliers, with a total of 21 unique Indian suppliers identified in the trade data. The top five suppliers account for 77.1% of the total import value, indicating a moderate level of concentration. This distribution suggests that while DISTRIMEX relies heavily on a few key suppliers, it also maintains relationships with a broader network of suppliers, which can help mitigate risks associated with single-source dependency.

The shipment data reveals a stable relationship with these suppliers, as evidenced by the consistent number of shipments over the years. For instance, STRIDES PHARMA SCIENCE LIMITED has 332 shipments valued at $6.0 million, and SUBIRA PHARMACEUTICALS PRIVATE LIMITED has 203 shipments valued at $2.4 million. This consistency indicates a reliable supply chain and suggests that DISTRIMEX has established strong partnerships with these suppliers.

2Supply Chain Resilience

DISTRIMEX's supply chain resilience is supported by its diverse sourcing strategy, involving 21 unique Indian suppliers. This diversity reduces the risk associated with dependency on a single supplier and enhances the company's ability to adapt to potential disruptions. The consistent number of shipments from these suppliers over the years indicates stable and reliable relationships, further strengthening the supply chain's resilience.

Importing Pharmaceuticals into France — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for France

1Regulatory Authority & Framework

In France, the primary regulatory authority overseeing pharmaceutical imports is the National Agency for the Safety of Medicines and Health Products (ANSM). ANSM is responsible for ensuring the safety, efficacy, and quality of health products available in the French market. Key legislation governing pharmaceutical imports includes the Public Health Code, which outlines the requirements for marketing authorization, importation, and distribution of pharmaceutical products.

The marketing authorization pathway for Indian generics involves obtaining a Marketing Authorization (AMM) from ANSM. This process includes submitting a comprehensive dossier demonstrating the product's quality, safety, and efficacy. The dossier must comply with the European Medicines Agency (EMA) guidelines and may require additional data specific to the French market. Collaboration with local regulatory experts can facilitate this process and ensure compliance with all regulatory requirements.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in France are stringent. Importers must hold a wholesale distribution authorization issued by ANSM, which requires compliance with Good Distribution Practices (GDP). Additionally, imported products must be manufactured in facilities that adhere to Good Manufacturing Practices (GMP). The EU recognizes GMP certificates from countries with equivalent standards, such as WHO GMP and PIC/S certifications.

Distrimex. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

DISTRIMEX's product category focus, particularly on nutritional supplements and advanced antibiotics, aligns with the growing demand for health and wellness products in the French and African markets. The emphasis on nutritional supplements, which constitute 94.5% of their imports, reflects a strategic response to consumer trends favoring preventive healthcare and self-medication. The inclusion of advanced antibiotics, accounting for 5.5% of imports, indicates a commitment to addressing serious infections and supporting healthcare infrastructure.

The market demand driving these imports is influenced by factors such as an aging population, increasing health awareness, and the need for effective treatments for infectious diseases. DISTRIMEX's sourcing strategy ensures a steady supply of these products, meeting the needs of healthcare providers and consumers in their target markets.

2Sourcing Profile

DISTRIMEX's sourcing strategy for pharmaceutical products involves importing finished formulations, including tablets, capsules, syrups, and injections, from India. This approach allows them to offer a diverse product range without the complexities associated with raw API procurement. India's well-established pharmaceutical manufacturing industry, with its adherence to international quality standards, makes it a reliable source for these finished products.

India's role in DISTRIMEX's overall procurement strategy is significant, given the volume and diversity of products imported. The consistent shipment data indicates a stable and ongoing relationship, suggesting that India will continue to play a crucial role in DISTRIMEX's sourcing profile.

Frequently Asked Questions — Distrimex.

What products does Distrimex. import from India?

Distrimex. imports 4 pharmaceutical products across 2 categories. Top imports: Folic ($2.5M), Vitamin ($1.1M), Secnidazole ($115.2K), Ceftazidime ($95.0K).

Who supplies pharmaceuticals to Distrimex. from India?

Distrimex. sources from 21 verified Indian suppliers. The primary supplier is Strides Pharma Science Limited (44.8% of imports, $6.0M).

What is Distrimex.'s total pharmaceutical import value?

Distrimex.'s total pharmaceutical import value from India is $3.8M, based on 111 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Distrimex. focus on?

Distrimex. imports across 2 categories. The largest: Nutritional Supplements (94.5%), Advanced Antibiotics (5.5%).

Get Full Distrimex. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.